Schilling, K. G., Grussu, F., Ianus, A., Hansen, B., Howard, A. F. D., Barrett, R. L. C., . . . Cancer. (2025). Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2—Ex vivo imaging: Added value and acquisition: Part 2—Ex vivo imaging: Added value and acquisition. Magnetic Resonance in Medicine, 93, 2535-2560. https://doi.org/10.1002/mrm.30435
Chicago-Zitierstil (17. Ausg.)Schilling, Kurt G., et al. "Considerations and Recommendations from the ISMRM Diffusion Study Group for Preclinical Diffusion MRI: Part 2—Ex Vivo Imaging: Added Value and Acquisition: Part 2—Ex Vivo Imaging: Added Value and Acquisition." Magnetic Resonance in Medicine 93 (2025): 2535-2560. https://doi.org/10.1002/mrm.30435.
MLA-Zitierstil (9. Ausg.)Schilling, Kurt G., et al. "Considerations and Recommendations from the ISMRM Diffusion Study Group for Preclinical Diffusion MRI: Part 2—Ex Vivo Imaging: Added Value and Acquisition: Part 2—Ex Vivo Imaging: Added Value and Acquisition." Magnetic Resonance in Medicine, vol. 93, 2025, pp. 2535-2560, https://doi.org/10.1002/mrm.30435.